Hartford CT 乳腺癌临床试验
9项针对 乳腺癌的研究正在 Hartford及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
招募中3 期
- Smilow Cancer Hospital at Saint Francis, Hartford
- Smilow Cancer Hospital at Glastonbury, Glastonbury · 距离 5 英里
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
招募中
- Hartford Healthcare Institute, Hartford
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
招募中3 期
- Hartford Hospital, Hartford
- Smilow Cancer Hospital Care Center at Saint Francis, Hartford
- Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury · 距离 5 英里
- 以及另外 3 项
ATEMPT 2.0: Adjuvant T-DM1 vs TH
招募中2 期
- Smilow Cancer Hospital Care center at St. Francis, Hartford
- Smilow Cancer Hospital Care center at Glastonbury, Glastonbury · 距离 5 英里
Integrated Cancer Repository for Cancer Research
招募中观察性研究欢迎健康志愿者
- Hartford HealthCare Cancer Institute at Manchester Medical Hospital, Manchester · 距离 8 英里
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
招募中3 期
- Smilow Cancer Hospital at Saint Francis, Hartford
- Smilow Cancer Hospital - Glastonbury, Glastonbury · 距离 5 英里
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
招募中3 期
- Smilow Cancer Hospital Care Center at Saint Francis, Hartford
- Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury · 距离 5 英里
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
招募中2 期
- Hartford Healthcare, Hartford
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Hartford
其他城市的 乳腺癌试验
- New York City, NY136 项研究
- Houston, TX126 项研究
- Boston, MA112 项研究
- Nashville, TN81 项研究
- Los Angeles, CA73 项研究
- Edison, NJ68 项研究
- St. Louis, MO64 项研究
- Queens, NY64 项研究
- Durham, NC64 项研究
- Chicago, IL59 项研究
- Philadelphia, PA56 项研究
- Dallas, TX55 项研究
Hartford的其他研究
- 非小细胞肺癌12 项研究
- 肺癌11 项研究
- 重度抑郁症9 项研究
- 癌症（所有类型）9 项研究
- 神经母细胞瘤8 项研究
- 多发性骨髓瘤7 项研究
- 心力衰竭7 项研究
- 前列腺癌7 项研究
- 卵巢癌7 项研究
- 心血管疾病7 项研究
- 胰腺癌7 项研究
- 子宫内膜癌5 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。